These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 24252812

  • 1. Inverse correlation of Acinetobacter spp. resistance rate and ciprofloxacin utilization.
    Pavlovic RR, Jankovic SM.
    J Antibiot (Tokyo); 2014 Mar; 67(3):273-5. PubMed ID: 24252812
    [No Abstract] [Full Text] [Related]

  • 2. Stable carbapenem susceptibility rates among multidrug-resistant Acinetobacter spp. strains in a setting of high prevalence of carbapenem-resistant Pseudomonas aeruginosa.
    Zavascki AP, Soares FC, Superti SV, Silbert S, Silva FM, Barth AL.
    Int J Antimicrob Agents; 2007 Aug; 30(2):187-9. PubMed ID: 17452093
    [No Abstract] [Full Text] [Related]

  • 3. [Evaluation of antibiotic resistance patterns of Pseudomonas aeruginosa and Acinetobacter spp. strains isolated from intensive care patients between 2000-2002 and 2003-2006 periods in Dokuz Eylul University Hospital, Izmir].
    Yüce A, Yapar N, Eren Kutsoylu O.
    Mikrobiyol Bul; 2009 Apr; 43(2):195-202. PubMed ID: 19621603
    [Abstract] [Full Text] [Related]

  • 4. In vitro selection of resistance in Pseudomonas aeruginosa and Acinetobacter spp. by levofloxacin and ciprofloxacin alone and in combination with beta-lactams and amikacin.
    Drago L, De Vecchi E, Nicola L, Tocalli L, Gismondo MR.
    J Antimicrob Chemother; 2005 Aug; 56(2):353-9. PubMed ID: 15967767
    [Abstract] [Full Text] [Related]

  • 5. Investigation of synergism of meropenem and ciprofloxacin against Pseudomonas aeruginosa and Acinetobacter strains isolated from intensive care unit infections.
    Ermertcan S, Hoşgör M, Tünger O, Coşar G.
    Scand J Infect Dis; 2001 Aug; 33(11):818-21. PubMed ID: 11760161
    [Abstract] [Full Text] [Related]

  • 6. Activity of meropenem and comparators against Pseudomonas aeruginosa and Acinetobacter spp. isolated in the MYSTIC Program, 2002-2004.
    Unal S, Garcia-Rodriguez JA.
    Diagn Microbiol Infect Dis; 2005 Dec; 53(4):265-71. PubMed ID: 16360550
    [Abstract] [Full Text] [Related]

  • 7. Previous Antibiotic Exposure and Antimicrobial Resistance Patterns of Acinetobacter spp. and Pseudomonas aeruginosa Isolated from Patients with Nosocomial Infections.
    Djordjevic ZM, Folic MM, Jankovic SM.
    Balkan Med J; 2017 Dec 01; 34(6):527-533. PubMed ID: 29215335
    [Abstract] [Full Text] [Related]

  • 8. Activity of levofloxacin and ciprofloxacin in combination with cefepime, ceftazidime, imipenem, piperacillin-tazobactam and amikacin against different Pseudomonas aeruginosa phenotypes and Acinetobacter spp.
    Drago L, De Vecchi E, Nicola L, Colombo A, Guerra A, Gismondo MR.
    Chemotherapy; 2004 Oct 01; 50(4):202-10. PubMed ID: 15452399
    [Abstract] [Full Text] [Related]

  • 9. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
    Alişkan H, Colakoğlu S, Turunç T, Demiroğlu YZ, Erdoğan F, Akin S, Arslan H.
    Mikrobiyol Bul; 2008 Apr 01; 42(2):321-9. PubMed ID: 18697430
    [Abstract] [Full Text] [Related]

  • 10. Resistance rates of Pseudomonas aeruginosa and Acinetobacter species causing ventilator-associated pneumonia do not always correlate with utilisation of antibiotics.
    Jankovic S, Djordjevic Z, Matovic M.
    J Hosp Infect; 2011 Jan 01; 77(1):77-8. PubMed ID: 21122946
    [No Abstract] [Full Text] [Related]

  • 11. Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program.
    Sader HS, Castanheira M, Mendes RE, Toleman M, Walsh TR, Jones RN.
    Int J Antimicrob Agents; 2005 Jan 01; 25(1):57-61. PubMed ID: 15620827
    [Abstract] [Full Text] [Related]

  • 12. Treatment options for multidrug-resistant nonfermenters.
    Briceño DF, Quinn JP, Villegas MV.
    Expert Rev Anti Infect Ther; 2010 Mar 01; 8(3):303-15. PubMed ID: 20192684
    [Abstract] [Full Text] [Related]

  • 13. Characterization and changing minimum inhibitory concentration (MIC) of Acinetobacter species from a tertiary care setup.
    Capoor MR, Nair D, Srivastava L, Gupta B, Aggarwal P.
    J Commun Dis; 2005 Jun 01; 37(2):99-107. PubMed ID: 16749272
    [Abstract] [Full Text] [Related]

  • 14. Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy.
    Zavascki AP, Carvalhaes CG, Picão RC, Gales AC.
    Expert Rev Anti Infect Ther; 2010 Jan 01; 8(1):71-93. PubMed ID: 20014903
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand.
    Koomanachai P, Tiengrim S, Kiratisin P, Thamlikitkul V.
    Int J Infect Dis; 2007 Sep 01; 11(5):402-6. PubMed ID: 17291803
    [Abstract] [Full Text] [Related]

  • 16. Doripenem vs meropenem against Pseudomonas and Acinetobacter.
    Goyal K, Gautam V, Ray P.
    Indian J Med Microbiol; 2012 Sep 01; 30(3):350-1. PubMed ID: 22885206
    [Abstract] [Full Text] [Related]

  • 17. Comprehensive in vitro evaluation of cefepime combined with aztreonam or ampicillin/sulbactam against multi-drug resistant Pseudomonas aeruginosa and Acinetobacter spp.
    Sader HS, Jones RN.
    Int J Antimicrob Agents; 2005 May 01; 25(5):380-4. PubMed ID: 15848291
    [Abstract] [Full Text] [Related]

  • 18. Stable polymyxin B susceptibility to Pseudomonas aeruginosa and Acinetobacter spp. despite persistent recovery of these organisms from respiratory secretions of patients with ventilator-associated pneumonia treated with this drug.
    Zavascki AP, Li J, Nation RL, Superti SV, Barth AL, Lutz L, Ramos F, Boniatti MM, Goldani LZ.
    J Clin Microbiol; 2009 Sep 01; 47(9):3064-5. PubMed ID: 19587305
    [No Abstract] [Full Text] [Related]

  • 19. Acinetobacter spp. and time-kill studies.
    Lopardo HA.
    J Antimicrob Chemother; 2008 Feb 01; 61(2):464; author reply 464-6. PubMed ID: 18033781
    [No Abstract] [Full Text] [Related]

  • 20. Metallo beta lactamases in Pseudomonas aeruginosa and Acinetobacter species.
    Gupta V.
    Expert Opin Investig Drugs; 2008 Feb 01; 17(2):131-43. PubMed ID: 18230049
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.